Ten Harkel Arend Derk Jan, Cransberg Karlien, Van Osch-Gevers Magdalena, Nauta Jeroen
Department of Pediatric Cardiology, Erasmus MC-Sophia, Rotterdam, The Netherlands.
Nephrol Dial Transplant. 2009 Jun;24(6):1987-91. doi: 10.1093/ndt/gfp049. Epub 2009 Feb 18.
Cardiovascular disease is the leading cause of death in children with end-stage renal disease. We investigated the presence of cardiac systolic and diastolic dysfunction in patients on peritoneal dialysis or after renal transplantation. Methods and results. Fourteen patients on peritoneal dialysis for a mean of 1.4 years (range 0.1-5.3) and 39 patients with a functioning kidney transplant for a median time of 3.3 years (range 1.2-14.5) were studied. These patients were compared to 153 age-matched healthy controls. As assessed by echocardiography, both dialysis and transplant patients showed left ventricular dysfunction. Systolic tissue Doppler values were lower as compared to controls. Mitral E/A ratios were significantly lower as well, indicating diastolic dysfunction (transplant 1.82 +/- 0.58 versus 2.15 +/- 0.63, P < 0.01; dialysis patients 1.57 +/- 0.73 versus 2.31 +/- 0.52, P < 0.01). Also, tissue Doppler values were different, showing an increased E/E' ratio in the patients, indicating diastolic dysfunction (transplant 9.49 +/- 1.71 versus 7.50 +/- 1.60, P < 0.01; dialysis patients 11.90 +/- 2.11 versus 8.10 +/- 1.24, P < 0.01). The left ventricular mass index was increased in the transplant patients (controls 25 +/- 7 g/m(2.7); transplant 59 +/- 64 g/m(2.7); P < 0.01), as well as in the dialysis patients (controls 28 +/- 7 g/m(2.7); dialysis 43 +/- 11 g/m(2.7); P < 0.01) and was associated with systolic hypertension (R = 0.46, P < 0.05). High parathyroid hormone (PTH) levels, more prevalent in dialysis patients, were associated with abnormal E/A and E/E' ratios.
Abnormalities in diastolic function are present in both peritoneal dialysis and renal transplanted patients. In the dialysis group, abnormalities in calcium-phosphate metabolism are associated with diastolic dysfunction. Cardiac hypertrophy was noted in both patient groups and was associated with systolic hypertension.
心血管疾病是终末期肾病患儿的主要死因。我们调查了接受腹膜透析或肾移植患者的心脏收缩和舒张功能障碍情况。方法与结果。研究了14例平均腹膜透析1.4年(范围0.1 - 5.3年)的患者和39例肾移植功能良好、中位时间为3.3年(范围1.2 - 14.5年)的患者。将这些患者与153名年龄匹配的健康对照者进行比较。经超声心动图评估,透析患者和移植患者均表现出左心室功能障碍。与对照组相比,组织多普勒收缩期值较低。二尖瓣E/A比值也显著降低,表明存在舒张功能障碍(移植患者1.82±0.58对2.15±0.63,P<0.01;透析患者1.57±0.73对2.31±0.52,P<0.01)。此外,组织多普勒值也不同,患者的E/E'比值升高,表明存在舒张功能障碍(移植患者9.49±1.71对7.50±1.60,P<0.01;透析患者11.90±2.11对8.10±1.24,P<0.01)。移植患者的左心室质量指数升高(对照组25±7g/m².⁷;移植患者59±64g/m².⁷;P<0.01),透析患者也是如此(对照组28±7g/m².⁷;透析患者43±11g/m².⁷;P<0.01),且与收缩期高血压相关(R = 0.46,P<0.05)。透析患者中更常见的高甲状旁腺激素(PTH)水平与异常的E/A和E/E'比值相关。
腹膜透析患者和肾移植患者均存在舒张功能异常。在透析组中,钙磷代谢异常与舒张功能障碍相关。两个患者组均观察到心脏肥大,并与收缩期高血压相关。